Prosecution Insights
Prosecution Insights
26 pending office actions • 18 art units • 26 examiners • 0 of 26 (0%) have an AI response strategy ready • 14 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 26 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 26 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 16 (62%) |
| §102 only | 1 (4%) |
| §112 only | 4 (15%) |
| No statute on record | 5 (19%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| WELLS, LAUREN QUINLAN | 1 | 45.6% | +58.7% |
| MUSTANSIR, ABID A | 1 | 77.9% | +12.0% |
| BEANE, RANDALL L | 1 | 32.5% | +37.8% |
| NOBLE, MARCIA STEPHENS | 1 | 67.0% | +40.2% |
| DUNN, LINDSAY MICHELLE | 1 | 100.0% | +0.0% |
| MAHLUM, JONATHAN DAVIS | 1 | 57.7% | +6.9% |
| DIBRINO, MARIANNE | 1 | 43.3% | +41.2% |
| BUTTICE, AUDREY L | 1 | 45.8% | +21.5% |
| KELLY, ROBERT M | 1 | 74.1% | +24.6% |
| PHAM, KATHERINE-PH MINH | 1 | 53.6% | +56.7% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18261983 | BONE-SPECIFIC DELIVERY OF POLYPEPTIDES | DUNN, LINDSAY MICHELLE | 17d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18245281 | CYTOTOXIC AND COSTIMULATORY CHIMERIC ANTIGEN RECEPTORS | BUTTICE, AUDREY L | 119d overdue |
| 18235533 | BENEFITS OF SUPPLEMENTATION WITH N-ACETYLCYSTEINE AND GLYCINE TO IMPROVE GLUTATHIONE LEVELS | BEANE, RANDALL L | 118d overdue |
| 18578641 | ENERGY WAVE REFRACTION AND METHODOLOGY TO DETECT GASTRIC DISTENTION AND PREVENT ASPIRATION | MUSTANSIR, ABID A | 42d overdue |
| 18301048 | TARGETING OF SRC-3 IN IMMUNE CELLS AS AN IMMUNOMODULATORY THERAPEUTIC FOR THE TREATMENT OF CANCER | DIBRINO, MARIANNE | 19d overdue |
| 18017302 | DESIGN OF 3D-PRINTED NASOPHARYNGEAL SWABS | PHAM, KATHERINE-PH MINH | 10d overdue |
| 18663524 | Fenfluramine for Treatment of Conditions Associated with Spreading Depolarization | WELLS, LAUREN QUINLAN | 14d |
| 18018552 | UNIVERSAL ANTIGEN-SPECIFIC T CELL BANKS AND METHODS OF MAKING AND USING THE SAME THERAPEUTICALLY | KELLY, ROBERT M | 16d |
| 18276164 | Engineered NKT Cells for Expansion and In Vivo Preservation and Methods of Use for the Control of Tumor Cells | NOBLE, MARCIA STEPHENS | 71d |
| Art Unit | Apps |
|---|---|
| 3791 | 3 |
| 1654 | 2 |
| 1644 | 2 |
| 1641 | 2 |
| 1638 | 2 |
| 1631 | 2 |
| 1642 | 2 |
| 1622 | 1 |
| 1632 | 1 |
| 1625 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18663524 | Fenfluramine for Treatment of Conditions Associated with Spreading Depolarization | WELLS, LAUREN QUINLAN | 1622 | §103 | Non-Final OA | 14d | Pending | May 14, 2024 |
| 18578641 | ENERGY WAVE REFRACTION AND METHODOLOGY TO DETECT GASTRIC DISTENTION AND PREVENT ASPIRATION | MUSTANSIR, ABID A | 3791 | §103 | Non-Final OA | 42d overdue | Pending | Jan 11, 2024 |
| 18235533 | BENEFITS OF SUPPLEMENTATION WITH N-ACETYLCYSTEINE AND GLYCINE TO IMPROVE GLUTATHIONE LEVELS | BEANE, RANDALL L | 1654 | §112 | Non-Final OA | 118d overdue | Pending | Aug 18, 2023 |
| 18276164 | Engineered NKT Cells for Expansion and In Vivo Preservation and Methods of Use for the Control of Tumor Cells | NOBLE, MARCIA STEPHENS | 1632 | §112 | Non-Final OA | 71d | Pending | Aug 07, 2023 |
| 18261983 | BONE-SPECIFIC DELIVERY OF POLYPEPTIDES | DUNN, LINDSAY MICHELLE | 1644 | §103 | Non-Final OA | 17d overdue | Pending | Jul 18, 2023 |
| 18039661 | NOVEL RIPK1 KINASE TARGETING PROTACS AND METHODS OF USE THEREOF | MAHLUM, JONATHAN DAVIS | 1625 | §103 | Non-Final OA | 14d | Pending | May 31, 2023 |
| 18301048 | TARGETING OF SRC-3 IN IMMUNE CELLS AS AN IMMUNOMODULATORY THERAPEUTIC FOR THE TREATMENT OF CANCER | DIBRINO, MARIANNE | 1641 | §102 | Non-Final OA | 19d overdue | Pending | Apr 14, 2023 |
| 18245281 | CYTOTOXIC AND COSTIMULATORY CHIMERIC ANTIGEN RECEPTORS | BUTTICE, AUDREY L | 1647 | §103 | Non-Final OA | 119d overdue | Pending | Mar 14, 2023 |
| 18018552 | UNIVERSAL ANTIGEN-SPECIFIC T CELL BANKS AND METHODS OF MAKING AND USING THE SAME THERAPEUTICALLY | KELLY, ROBERT M | 1638 | §103 | Non-Final OA | 16d | Pending | Jan 28, 2023 |
| 18017302 | DESIGN OF 3D-PRINTED NASOPHARYNGEAL SWABS | PHAM, KATHERINE-PH MINH | 3781 | §103 | Final Rejection | 10d overdue | Pending | Jan 20, 2023 |
| 17997171 | TREATMENT AND PREVENTION OF ALLOREACTIVITY USING VIRUS-SPECIFIC IMMUNE CELLS EXPRESSING CHIMERIC ANTIGEN RECEPTORS | DAHLE, CHUN WU | 1641 | Other | Non-Final OA | 3d overdue | Pending | Oct 26, 2022 |
| 17997161 | TREATMENT AND PREVENTION OF CANCER USING VIRUS-SPECIFIC IMMUNE CELLS EXPRESSING CHIMERIC ANTIGEN RECEPTORS | CHATTIN, AMY MARIE | 1643 | Other | Final Rejection | 73d overdue | Pending | Oct 26, 2022 |
| 17973738 | DEVICES, SYSTEMS, AND METHODS FOR DIAGNOSING TREATING AND MONITORING CHRONIC PELVIC PAIN | TOTH, KAREN E | 3791 | §112 | Final Rejection | 91d overdue | Pending | Oct 26, 2022 |
| 17995540 | DAILY LIVING MONITORING AND MANAGEMENT SYSTEM | EPPERT, LUCY CLARE | 3791 | §103 | Final Rejection | 20d | Pending | Oct 05, 2022 |
| 17934501 | METHODS FOR INDUCING SELECTIVE APOPTOSIS | LEONARD, ARTHUR S | 1631 | Other | Final Rejection | 38d overdue | Pending | Sep 22, 2022 |
| 17906490 | SARS-COV2-SPECIFIC T CELL COMPOSITIONS AND THEIR USE IN TREATING AND PREVENTING CORONAVIRUS AND OTHER RESPIRATORY VIRUS INFECTIONS | BARRON, SEAN C | 1653 | Other | Final Rejection | 8d | Pending | Sep 16, 2022 |
| 17757881 | T CELL PERFORMANCE ASSAY AS A PROGNOSTIC FACTOR FOR CLINICAL OUTCOME | SULLIVAN, DENNIS JOHN | 1642 | §103 | Final Rejection | 34d | Pending | Jun 22, 2022 |
| 17757058 | RETINA REGENERATION THROUGH EPIGENETICS MANIPULATION | LIEB, JEANETTE M | 1654 | §103 | Non-Final OA | 13d | Pending | Jun 08, 2022 |
| 17774848 | METHOD FOR PRODUCING CYTOTOXIC EFFECTOR MEMORY T-CELLS FOR CAR T-CELL TREATMENT OF CANCER | HILL, KEVIN KAI | 1638 | §103 | Final Rejection | 3d overdue | Pending | May 05, 2022 |
| 17661135 | PREDICTION OF THE ONSET OF CRITICAL LIMB THREATENING ISCHEMIA (CLTI) | KOETH, MICHELLE M | 2671 | §103 | Non-Final OA | 86d overdue | Pending | Apr 28, 2022 |
| 17576597 | DENDRITIC CELL IMMUNOTHERAPY | JUEDES, AMY E | 1644 | Other | Final Rejection | 132d overdue | Pending | Jan 14, 2022 |
| 17596923 | MULTIFUNCTIONAL BIOMESH FOR SURGICAL HERNIA REPAIR | MCGRATH, ERIN E | 3771 | §103 | Final Rejection | 23d | Pending | Dec 21, 2021 |
| 17593747 | MULTI-RESPIRATORY VIRUS ANTIGEN-SPECIFIC T CELLS AND METHODS OF MAKING AND USING THE SAME THERAPEUTICALLY | PARKIN, JEFFREY S | 1671 | §103 | Non-Final OA | 27d | Pending | Sep 23, 2021 |
| 17287972 | ONCOLYTIC VIROTHERAPY AND IMMUNOTHERAPY | BATES, KEENAN ALEXANDER | 1631 | §103 | Final Rejection | 44d overdue | Pending | Apr 22, 2021 |
| 17274529 | PRECISION DIAGNOSIS OF CLOSTRIDIOIDES DIFFICILE INFECTION USING A SYSTEMS-BASED BIOMARKERS | HINES, JANA A | 1645 | §103 | Final Rejection | 9d overdue | Pending | Mar 09, 2021 |
| 16971992 | TISSUE ANALYSIS BY MASS SPECTROMETRY | GODDARD, LAURA B | 1642 | §112 | Non-Final OA | 71d overdue | Pending | Aug 21, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial